Bright Minds Biosciences Inc (DRUG.CX)
49.40
+4.22
(+9.34%)
CAD |
CNSX |
Nov 22, 16:00
Bright Minds Biosciences Shareholders Equity (Quarterly): 6.099M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 6.099M |
March 31, 2024 | 5.685M |
December 31, 2023 | 6.033M |
September 30, 2023 | 6.598M |
June 30, 2023 | 7.726M |
March 31, 2023 | 8.946M |
December 31, 2022 | 10.97M |
September 30, 2022 | 10.54M |
Date | Value |
---|---|
June 30, 2022 | 8.434M |
March 31, 2022 | 10.76M |
December 31, 2021 | 14.92M |
September 30, 2021 | 19.40M |
June 30, 2021 | 21.89M |
March 31, 2021 | 25.33M |
December 31, 2020 | 2.089M |
September 30, 2020 | 0.7293M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
0.7293M
Minimum
Sep 2020
25.33M
Maximum
Mar 2021
10.38M
Average
8.690M
Median
Shareholders Equity (Quarterly) Benchmarks
4Front Ventures Corp | -65.60M |
Green Thumb Industries Inc | 2.398B |
Lowell Farms Inc | 5.680M |
StateHouse Holdings Inc | -246.16M |
Vireo Growth Inc | -14.86M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.278M |
Total Liabilities (Quarterly) | 0.1786M |